# A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-dose-response-multicenter-phase-ii-study-of-radium-223-chloride-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sten Nilsson,Peter Strang,A. Aksnes,Lars Franzén,Patrick Olivier,A Pecking,J. Staffurth,S. Vasanthan,Charlotte Andersson,Øyvind S. Bruland |
| Citations | 246 |
| DOI | 10.1016/j.ejca.2011.12.023 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.ejcancer.com/article/S0959804911010720/pdf |
| OpenAlex ID | https://openalex.org/W2156451504 |
| PMID | 22341993 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Peter Strang](https://scholariq.org/researchers/peter-strang/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.